slide1
Download
Skip this Video
Download Presentation
Designing Anti-Tumor Drugs Using Natural and Synthetic Agents

Loading in 2 Seconds...

play fullscreen
1 / 41

Designing Anti-Tumor Drugs Using Natural and Synthetic Agents - PowerPoint PPT Presentation


  • 348 Views
  • Uploaded on

0 Designing Anti-Tumor Drugs Using Natural and Synthetic Agents Herman L. Holt, Jr. University of North Carolina, Asheville Asheville, NC 28804 ASHEVILLE Medicinal Chemistry Folklore 0

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Designing Anti-Tumor Drugs Using Natural and Synthetic Agents' - bernad


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

0

Designing Anti-Tumor Drugs Using Natural and Synthetic Agents

Herman L. Holt, Jr.

University of North Carolina, Asheville

Asheville, NC 28804

ASHEVILLE

slide2

Medicinal Chemistry Folklore

0

  • Medicinal chemistry is the science that deals with the discovery of therapeutic chemicals and their development into useful medicines
  • Medicinal chemistry has been practiced for thousands of years
  • The earliest written records of the African, Chinese, Indian, South American, and Mediterranean cultures and biblical languages describe the therapeutic effects of various plant concoctions
  • Man has search for cures by chewing on bark, roots, leaves and berries

Dr. Milton Brown, University of Virginia

slide3

0

...Milton Brown, a native of Baltimore, MD, received his bachelor’s degree from Oakwood College in 1987, a Ph.D. in organic chemistry from the University of Alabama, and a M.D. from the University of Virginia, where he currently serves as an associate professor of Chemistry and principal investigator for various NIH funded research projects. He has published in

numerous prestigious academic journals as well as receiving awards in research and teaching.

a father of modern medicinal chemistry

0

A Father of Modern Medicinal Chemistry
  • Edward E. Smissman, University of Kansas
    • Smissman Award of the ACS Division of Medicinal Chemistry named in his honor
tsung ying t y shen university of virginia professor emeritus

0

Tsung Ying (T.Y.) ShenUniversity of VirginiaProfessor Emeritus

Famous for Synthesis and Discovery of the Mechanism of Action of:

Indomethacin

Sulindac

Diflunisal

Other anti-inflammatory-analgesic (NSAIDS) and immunoregulators

More than 210 U.S. Patents and scientific publications

slide7

0

  • Medicinal Chemistry is defined as an interdisciplinary science situated at the interface of organic chemistry and life sciences (such as biochemistry, pharmacology, molecular biology, immunology, pharmacokinetics and toxicology) on one side and chemistry-based disciplines (such as physical chemistry, crystallography, spectroscopy and computer-based information technologies) on the other.

Medicinal Chemistry

Chemistry based

disciplines

Organic Chemistry

Life Sciences

slide8

0

  • Terms more or less synonymous with medicinal chemistry
    • Pharmacochemistry
    • Molecular pharmacochemistry
    • Drug design
    • Selective toxicity
definition and objectives

0

Definition and Objectives
  • Medicinal chemistry relates to the design and production of compounds that can be used in medicine for the prevention, treatment or cure of human and animal diseases
  • Medicinal chemistry covers three critical steps:
  • A discovery step consisting of the identification and production of new active substances usually called lead compounds. Leads can originate from synthetic organic chemistry, from natural sources or from biotechnological processes.
  • An optimization step that deals mainly with the synthetic modification of the lead structure in order to improve potency, selectivity and lessen toxicity. Its characteristics are the establishment and analysis of structure-activity relationships (SAR).
  • A development step consisting of:
    • the optimization of the synthetic route for bulk production
    • modification of the pharmacokinetic and pharmaceutical properties of the active substance to render it suitable for clinical use. This may cover optimization of properties associated with:
      • Chemical formulation
      • Solubility
      • Elimination of unpleasant taste or irritation
      • Reduction of pain at site of injection
challenges for medicinal chemistry

0

Challenges for Medicinal Chemistry
  • Medicinal chemist must excel in organic synthesis and understanding modern approaches to structure-activity analysis. Medicinal chemist are involved in the design, synthesis, optimization and selection of new lead compounds
  • A survey of a range of company hiring representatives suggested these desired qualities:
    • Ability to fit a multidisciplinary team
    • Ability to search for novel molecules
    • Increased knowledge of how to synthesize molecules for focused biological testing
    • Understanding of the reasons for making compounds
    • Understanding drug design
    • Insight in SAR with insufficient data
    • Knowledge in collateral fields (pathophysiology, cell biology, genetics)
    • Familiarity with new techniques
slide11

0

Designing Anti-Tumor Drugs Using Natural and Synthetic Agents

Herman L. Holt, Jr.

University of North Carolina, Asheville

Asheville, NC 28804

ASHEVILLE

tubulin

0

TUBULIN
  • Taxoid Site
  • Vanca Alkaloid
  • Domain
  • Colchicine Site
  • Globular Protein
microtubules

0

MICROTUBULES
  • Tubulin Polymers
mitotic spindle

0

MITOTIC SPINDLE
  • Composed of Microtubules and associated proteins
  • Needed for cellular division
microtubules15

0

MICROTUBULES
  • Tubulin Polymers
what is the mtt assay

0

What is the MTT assay?

•Cultured cancer cells are grown in the presence of potential

drug for a specific time period (e.g. 72, 96 h)

  • The amount of viable cells remaining can be determined spectrophotometrically
  • Living cells convert the yellow water soluble-tetrazolium
  • salt into an insoluble purple formazan crystal
  • Crystal is dissolved in a suitable solvent (e.g. DMSO,
  • acid-IPA) and the absorbance at 570 nm is obtained
  • A dose response curve is plotted and the concentration
  • at 50% cell growth is obtained
slide17

0

MTT = 3-(4’,5’-dimethylthiazol-2’-yl)-2,5-diphenyltetrazolium bromide

cisplatin

0

CISPLATIN
  • Anti-cancer agent
  • Ovarian
  • Testicular
  • Lung
  • Breast
cisplatin19

0

CISPLATIN
  • Cleaves DNA
slide20

0

TAXOL

  • Pacific Yew Tree
  • Anti-cancer agent
  • Ovarian
  • Testicular
  • Lung
  • Breast
slide21

0

TAXOL

  • Stabilizes microtubules and prevents
  • disassembly and re-polymerization
vancomycin

0

VANCOMYCIN
  • Tubulin polymerization inhibitor
slide23

COLCHICINE

0

  • Meadow saffron or autumn Crocus
  • poisonous

Copyright @ 1997 Alice B. Russell, James W. Hardin, Larry Grand

slide24

0

COLCHICINE

  • Tubulin binder
  • Inhibits tubulin polymerization
slide25

0

COMBRETASTATIN

  • Derived from the African bush willow tree, Combretum caffrum
slide26

0

COMBRETASTATIN

  • Tubulin binder
  • Inhibits tubulin polymerization
slide28

0

  • Combretastatin A-4 is the most developed and furthest along
  • in clinical studies among the vascular targeting agents.
slide30

0

http://www.oxigene.com/vascular/video1.asp

slide31

0

HETEROCYCLE ANALOGS OF COMBRETASTATIN

slide32

0

HETEROCYCLE ANALOGS OF COMBRETASTATIN

Pati, Wicks, Holt, LeBlanc, Weisbruch, Forrest, Lee Heterocyclic Communications2005, in press.

Maintain structural rigidity

Increase water solubility

slide33

0

COMBRETASTATIN AND TRIAZOLE SYNTHESIS

slide34

0

COMBRETASTATIN AND TRIAZOLE SYNTHESIS

slide35

0

AZIRIDINE ANALOGS OF COMBRETASTATINS

slide36

0

AZIRIDINE TYPE ANALOGS OF COMBRETASTATINS

slide37

0

MITOMYCINS

  • Anti-cancer agent
  • Bladder
slide38

0

MITOMYCINS

  • DNA Alkylating Agent
slide39

0

MITOMYCINS

  • SYNTHESIS IS CURRENTLY IN PROGRESS
  • RESEARCH PRESENTED AT:
  • ►Southeast Regional Meeting of the American
  • Chemical Society (joint meeting with Southwest region)
  • ► North Carolina Undergraduate Research Symposium
  • ► National Conference on Undergraduate Research
  • (Held at UNCA in celebration of its 20th Anniversary)
slide40

0

REFERENCES

http://en.wikipedia.org/wiki/Main_Page

http://www.ces.ncsu.edu/depts/hort/consumer/poison/Colchau.htm

Chemical and Engineering News2005, 83(5), several pages therein.

slide41

0

MUCH APPRECIATION

Jessica Maddox

David Mabe

Regan LeBlanc

John Dickson

Dr. Moses Lee

Dr. Toni Brown

Dr. Karen Buchmueller

Lee Group

UNC-Asheville

Furman University

NSF-REU

NSF-MRPG

ad